Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-06

FDA Approved: REVATIO — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for REVATIO (sildenafil citrate) submitted by Viatris Specialty LLC. The action expands the approved use/label for the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REVATIO (SILDENAFIL CITRATE)

Snippet

SUPPL AP for REVATIO (SILDENAFIL CITRATE)